chartexchange

VXRT
VAXART INC
stockOTC

EODNov 18, 2026
0.355USD0.000%(0.00)245,774
Loading…
Loading…
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$0.36
Beta
1.19
52-Week High
$0.84 2026-01-12
52-Week Low
$0.33 2025-11-24
SMA 50
$0.44
SMA 200
$0.57
Avg. Vol 10D
295,756
Avg. Vol 30D
299,769
Avg. Vol 90D
288,564
Relative Vol
1.34
228.22M
239.66M
436
Feb 14, 2018 · 1-for-11 (reverse)
VXRT Profile

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company's proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.

VXRT Performance
PeriodPriceDateChangeBeta
1W0.372026-11-11-2.74%1.383
1M0.482026-10-19-25.34%1.193
3M0.502026-08-18-28.29%1.104
6M0.632026-05-18-43.42%1.080
1Y0.392025-11-18-9.94%1.191
2Y0.612024-11-18-41.80%—
5Y7.062021-11-18-94.97%1.646
VXRT Stock Summary

VAXART INC (OTC:VXRT) stock price today is $0.36, and today's volume is 400,756. VXRT is down 1.856% today. The 30 day average volume is 299,769. VXRT market cap is $81.02M with 228.22M shares outstanding.